DualityBio-B (HKEX: 09606) has announced a share buyback transaction. On June 4, 2026, the company utilized HK$6.4558 million to repurchase 34,000 of its own shares.
In a separate transaction, the company issued 10,100 ordinary shares. These shares were issued as a result of exercising options granted under a pre-IPO share incentive scheme. This scheme was originally adopted on February 28, 2021, and subsequently amended on June 25, 2023.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments